---
:id: aHR0cDovL3d3dy5hY21lLXBoYXJtYS5jb20vVEVTVC9WMSNUSA==
:uri: http://www.acme-pharma.com/TEST/V1#TH
:rdf_type: http://www.assero.co.uk/Thesaurus#Thesaurus
:label: Test Thesaurus
:tagged: []
:has_state:
  :id: aHR0cDovL3d3dy5hY21lLXBoYXJtYS5jb20vVEVTVC9WMSNUSF9SUw==
  :uri: http://www.acme-pharma.com/TEST/V1#TH_RS
  :rdf_type: http://www.assero.co.uk/ISO11179Registration#RegistrationState
  :registration_status: Incomplete
  :administrative_note: ''
  :effective_date: '2016-01-01T00:00:00+00:00'
  :until_date: '2016-01-01T00:00:00+00:00'
  :unresolved_issue: ''
  :administrative_status: ''
  :previous_state: Incomplete
  :multiple_edit: false
  :by_authority:
    :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvUkEjRFVOUzEyMzQ1Njc4OQ==
    :uri: http://www.assero.co.uk/RA#DUNS123456789
    :rdf_type: http://www.assero.co.uk/ISO11179Registration#RegistrationAuthority
    :organization_identifier: '123456789'
    :international_code_designator: DUNS
    :owner: true
    :ra_namespace:
      :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvTlMjQUNNRQ==
      :uri: http://www.assero.co.uk/NS#ACME
      :rdf_type: http://www.assero.co.uk/ISO11179Identification#Namespace
      :short_name: ACME
      :name: ACME Pharma
      :authority: www.acme-pharma.com
:has_identifier:
  :id: aHR0cDovL3d3dy5hY21lLXBoYXJtYS5jb20vVEVTVC9WMSNUSF9TSQ==
  :uri: http://www.acme-pharma.com/TEST/V1#TH_SI
  :rdf_type: http://www.assero.co.uk/ISO11179Identification#ScopedIdentifier
  :identifier: TEST
  :version_label: ''
  :version: 1
  :semantic_version: 0.1.0
  :has_scope:
    :id: aHR0cDovL3d3dy5hc3Nlcm8uY28udWsvTlMjQUNNRQ==
    :uri: http://www.assero.co.uk/NS#ACME
    :rdf_type: http://www.assero.co.uk/ISO11179Identification#Namespace
    :short_name: ACME
    :name: ACME Pharma
    :authority: www.acme-pharma.com
:has_previous_version: 
:origin: ''
:change_description: ''
:creation_date: '2020-02-22T17:32:44+01:00'
:last_change_date: '2020-02-22T17:32:44+01:00'
:explanatory_comment: ''
:is_top_concept_reference:
- :id: aHR0cDovL3d3dy5hY21lLXBoYXJtYS5jb20vVEVTVC9WMSNUSF9UTUMz
  :uri: http://www.acme-pharma.com/TEST/V1#TH_TMC3
  :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
  :label: ''
  :tagged: []
  :enabled: true
  :optional: false
  :ordinal: 3
  :reference: http://www.acme-pharma.com/A00001/V1#A00001
  :context: 
- :id: aHR0cDovL3d3dy5hY21lLXBoYXJtYS5jb20vVEVTVC9WMSNUSF9UTUM0
  :uri: http://www.acme-pharma.com/TEST/V1#TH_TMC4
  :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
  :label: ''
  :tagged: []
  :enabled: true
  :optional: false
  :ordinal: 4
  :reference: http://www.cdisc.org/C66783/V4#C66783
  :context: 
- :id: aHR0cDovL3d3dy5hY21lLXBoYXJtYS5jb20vVEVTVC9WMSNUSF9UTUM1
  :uri: http://www.acme-pharma.com/TEST/V1#TH_TMC5
  :rdf_type: http://www.assero.co.uk/BusinessOperational#TMcReference
  :label: ''
  :tagged: []
  :enabled: true
  :optional: false
  :ordinal: 5
  :reference: http://www.cdisc.org/C66737/V4#C66737
  :context: 
:is_top_concept:
- :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY2NzgzL1Y0I0M2Njc4Mw==
  :uri: http://www.cdisc.org/C66783/V4#C66783
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: CDISC System Organ Class
  :tagged:
  - http://www.assero.co.uk/CSN#2070e714-3f5b-45d4-b1a3-5ff5d58cbce9
  :has_state: http://www.cdisc.org/C66783/V4#C66783_RS
  :has_identifier: http://www.cdisc.org/C66783/V4#C66783_SI
  :has_previous_version: 
  :origin: ''
  :change_description: ''
  :creation_date: '2007-05-31T00:00:00+00:00'
  :last_change_date: '2007-05-31T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C66783
  :notation: SOC
  :definition: Terms at the highest level of the CDISC system organ class terminology.
  :extensible: false
  :narrower:
  - http://www.cdisc.org/C66783/V4#C66783_C3371
  - http://www.cdisc.org/C66783/V4#C66783_C49403
  - http://www.cdisc.org/C66783/V4#C66783_C27574
  - http://www.cdisc.org/C66783/V4#C66783_C41198
  - http://www.cdisc.org/C66783/V4#C66783_C26726
  - http://www.cdisc.org/C66783/V4#C66783_C35117
  - http://www.cdisc.org/C66783/V4#C66783_C3009
  - http://www.cdisc.org/C66783/V4#C66783_C3430
  - http://www.cdisc.org/C66783/V4#C66783_C49399
  - http://www.cdisc.org/C66783/V4#C66783_C20188
  - http://www.cdisc.org/C66783/V4#C66783_C35814
  - http://www.cdisc.org/C66783/V4#C66783_C3507
  - http://www.cdisc.org/C66783/V4#C66783_C3262
  - http://www.cdisc.org/C66783/V4#C66783_C49405
  - http://www.cdisc.org/C66783/V4#C66783_C3079
  - http://www.cdisc.org/C66783/V4#C66783_C2893
  - http://www.cdisc.org/C66783/V4#C66783_C26767
  - http://www.cdisc.org/C66783/V4#C66783_C25218
  - http://www.cdisc.org/C66783/V4#C66783_C27669
  - http://www.cdisc.org/C66783/V4#C66783_C26835
  - http://www.cdisc.org/C66783/V4#C66783_C49404
  - http://www.cdisc.org/C66783/V4#C66783_C49401
  - http://www.cdisc.org/C66783/V4#C66783_C49402
  - http://www.cdisc.org/C66783/V4#C66783_C49400
  - http://www.cdisc.org/C66783/V4#C66783_C2990
  - http://www.cdisc.org/C66783/V4#C66783_C3959
  :extends: 
  :subsets: 
  :paired_with: 
  :refers_to: []
  :preferred_term: http://www.assero.co.uk/PT#2b19e0511fa043da5bcabadc83d7d5d1ac4b1dbe
  :synonym:
  - http://www.assero.co.uk/SYN#9f625ee992fa0b5103e70d741d9cbf11f1045ea7
  :is_ordered: 
  :is_ranked: 
- :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY2NzM3L1Y0I0M2NjczNw==
  :uri: http://www.cdisc.org/C66737/V4#C66737
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: Trial Phase
  :tagged:
  - http://www.assero.co.uk/CSN#2070e714-3f5b-45d4-b1a3-5ff5d58cbce9
  :has_state: http://www.cdisc.org/C66737/V4#C66737_RS
  :has_identifier: http://www.cdisc.org/C66737/V4#C66737_SI
  :has_previous_version: 
  :origin: ''
  :change_description: ''
  :creation_date: '2007-05-31T00:00:00+00:00'
  :last_change_date: '2007-05-31T00:00:00+00:00'
  :explanatory_comment: ''
  :identifier: C66737
  :notation: TPHASE
  :definition: 'Clinical trials are broken into three or four phases: Phase I tests
    a new drug or treatment for safety in a small group; Phase II expands the study
    to a larger group of people; Phase III expands the study to an even larger group
    of people to measure whether the treatment actually benefits patients, and whether
    its benefits exceed its risks; and Phase IV takes place after the drug or treatment
    has been licensed and marketed. (NCI)'
  :extensible: true
  :narrower:
  - http://www.cdisc.org/C66737/V4#C66737_C49686
  - http://www.cdisc.org/C66737/V4#C66737_C15601
  - http://www.cdisc.org/C66737/V4#C66737_C49688
  - http://www.cdisc.org/C66737/V4#C66737_C47865
  - http://www.cdisc.org/C66737/V4#C66737_C15602
  - http://www.cdisc.org/C66737/V4#C66737_C49689
  - http://www.cdisc.org/C66737/V4#C66737_C15600
  - http://www.cdisc.org/C66737/V4#C66737_C49687
  - http://www.cdisc.org/C66737/V4#C66737_C15694
  - http://www.cdisc.org/C66737/V4#C66737_C15603
  - http://www.cdisc.org/C66737/V4#C66737_C48660
  - http://www.cdisc.org/C66737/V4#C66737_C15693
  :extends: 
  :subsets: 
  :paired_with: 
  :refers_to: []
  :preferred_term: http://www.assero.co.uk/PT#ea316b4c8700efa4ad1f09c6a6565e2e8a8723c2
  :synonym:
  - http://www.assero.co.uk/SYN#73056984706139d0dc7464d5c079e1b1dca9efff
  :is_ordered: 
  :is_ranked: 
- :id: aHR0cDovL3d3dy5hY21lLXBoYXJtYS5jb20vQTAwMDAxL1YxI0EwMDAwMQ==
  :uri: http://www.acme-pharma.com/A00001/V1#A00001
  :rdf_type: http://www.assero.co.uk/Thesaurus#ManagedConcept
  :label: London Heathrow
  :tagged: []
  :has_state: http://www.acme-pharma.com/A00001/V1#A00001_RS
  :has_identifier: http://www.acme-pharma.com/A00001/V1#A00001_SI
  :has_previous_version: 
  :origin: ''
  :change_description: ''
  :creation_date: '2016-01-01T00:00:00+00:00'
  :last_change_date: '2019-12-15T20:50:53+01:00'
  :explanatory_comment: ''
  :identifier: A00001
  :notation: LHR
  :definition: A definition
  :extensible: false
  :narrower:
  - http://www.acme-pharma.com/A00001/V1#A00001_A000012
  - http://www.acme-pharma.com/A00001/V1#A00001_A000011
  :extends: 
  :subsets: 
  :paired_with: 
  :refers_to: []
  :preferred_term: http://www.assero.co.uk/PT#811134c7e968fad493503ef4bb858c4677c29f8a
  :synonym:
  - http://www.assero.co.uk/SYN#79c4ee2a8794ed9263677bae64ea01a6e9bb6472
  - http://www.assero.co.uk/SYN#e4626aa737c7a6111b853ba4eaf4ee1599bfb7b3
  :is_ordered: 
  :is_ranked: 
:reference:
  :id: aHR0cDovL3d3dy5hY21lLXBoYXJtYS5jb20vVEVTVC9WMSNUSF9SMQ==
  :uri: http://www.acme-pharma.com/TEST/V1#TH_R1
  :rdf_type: http://www.assero.co.uk/BusinessOperational#Reference
  :label: ''
  :tagged: []
  :enabled: true
  :optional: false
  :ordinal: 1
  :reference: http://www.cdisc.org/CT/V5#TH
  :context: 
:baseline_reference:
  :id: aHR0cDovL3d3dy5hY21lLXBoYXJtYS5jb20vVEVTVC9WMSNUSF9SMg==
  :uri: http://www.acme-pharma.com/TEST/V1#TH_R2
  :rdf_type: http://www.assero.co.uk/BusinessOperational#Reference
  :label: ''
  :tagged: []
  :enabled: true
  :optional: false
  :ordinal: 2
  :reference: http://www.cdisc.org/CT/V2#TH
  :context: 
